Sort
64,565 grants matching “drug discovery”
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology
$889,388Joyce E. Bischoff · Boston Children'S Hospital · R01 · FY2020 · HL
Regulatory landscape of the human genome: comparative and evolutionary analysis.
$889,376Ivan Ovcharenko · National Library Of Medicine · ZIA · FY2012 · LM
Immunology of aging and immunotherapy of aging-associated diseases
$889,306Arya Biragyn · National Institute On Aging · ZIA · FY2014 · AG
Immobilized Proteins In Drug Discovery
$889,094Irving William Wainer · National Institute On Aging · ZIA · FY2014 · AG
A Screening Library for Peptide-Activated GPCR's
$889,087Neurocrine Biosciences, Inc. · R44 · FY2002 · GM
INTERDISCIPLINARY APPROACH TO ALZHEIMER DRUG DISCOVERY
$889,059Nathan S. Kline Institute For Psych Res · P01 · FY2000 · AG
Common Stem Cell of Origin for Junctional and Gastric Adenocarcinoma
$888,662Frank D. McKeon · University Of Houston · R01 · FY2024 · CA
Targeting bacterial cell wall biogenesis for the development of novel antimicrob
$888,658Thomas G Bernhardt · Harvard Medical School · U19 · FY2015 · AI
Discovery of potent and selective neuropeptide Y Y2 receptor antagonist probes
$888,550Michael Darin Cameron · Scripps Research Institute, The · U01 · FY2011 · AA
Project 4 - Influenza - UAB
$888,530Richard J. Whitley · University Of Alabama At Birmingham · U19 · FY2021 · AI
Drug Discovery & Synthesis of Contraceptive Agents
$888,430Gunda I. Georg · University Of Minnesota · U01 · FY2012 · HD
Targeting bacterial cell wall biogenesis for the development of novel antimicrob
$888,429Thomas G Bernhardt · Harvard Medical School · U19 · FY2017 · AI
Clinical Pharmacology Training Program
$888,184Walter K. Kraft · Thomas Jefferson University · T32 · FY2024 · GM
Open Drug Discovery Center for Alzheimer's Disease
$888,105Allan I Levey · Emory University · U54 · FY2021 · AG
Open Drug Discovery Center for Alzheimer's Disease
$888,104Allan I Levey · Emory University · U54 · FY2022 · AG
Injectable naltrexone 2-month depot formulations
$888,085Kinam Park · Purdue University · UH3 · FY2022 · DA
Inhibitors of Coronavirus Fidelity and Cap Methylation as Broadly Applicable
$887,941Mark R Denison · University Of Alabama At Birmingham · U19 · FY2015 · AI
Rapid Development of a Lead Aromatic Aldehyde Derivative with both Oxygen Dependent and Novel, Oxygen Independent Anti-Sickling Effects: Building on a Paradigm Shift in Sickle Cell Disease Therapy
$887,907David Richard Light · Illexcor Therapeutics, Llc · R44 · FY2024 · HL
Cell-free assay technologies for the identification of active compounds
$887,458Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
NOVEL STRATEGIES FOR PLANT-DERIVED ANTICANCER AGENTS
$887,455University Of Illinois At Chicago · U19 · FY2002 · CA
Inhibitors and Probes of HIV-1 Cell Fusion
$887,367Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Optimization and evaluation of novel benzimidazoles for the treatment of Alzheimer's Disease
$887,312Kevin Hodgetts · Brigham And Women'S Hospital · U01 · FY2021 · AG
Nuclear Factor-kappaB in Ovarian Cancer
$887,215Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
West Virginia University Injury Control Research Center
$887,181Robert M Bossarte · West Virginia University · R49 · FY2017 · CE
Systematic Development of Novel, Druggable Cancer Targets
$887,144Michael E. Berens · Translational Genomics Research Inst · U01 · FY2012 · CA